Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyundai Venture Investment is a South Korea-based venture capital firm that invests in startups and emerging companies across multiple sectors, including information technology, manufacturing, healthcare, and life sciences. The firm appears to operate as an investment organization rather than as a drug developer, pharmaceutical company, or healthcare operating business. Public profiles describe its mission as supporting entrepreneurs and venture companies with promising technologies that may need financial and management backing. Its portfolio and investment activity span sectors such as biotechnology, oncology, healthcare, and broader technology markets across Asia. For biotech diligence purposes, Hyundai Venture Investment is best categorized as a venture investor with exposure to healthcare and life sciences rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyundai Venture Investment.